4CN-CUMYL-BUT7AICA

A synthetic cannabinoid

CaptionSynonyms

4CN-CUMYL-BUT7AICA

Drug Information
Image	200
Identifiers ATC Code DrugBank KEGG ChEBI ChEMBL		Chemical Data Molecular Weight

4CN-CUMYL-BUT7AICA is a synthetic cannabinoid that has been used in scientific research and is known for its potent agonistic activity at the cannabinoid receptors. It is part of a class of compounds that are often used in the development of new therapeutic agents, as well as in the study of the endocannabinoid system.

Chemical Structure and Properties

4CN-CUMYL-BUT7AICA is chemically classified as an indazole-based synthetic cannabinoid. Its structure includes a 4-cyanobutyl group attached to the indazole core, which is a common feature in many synthetic cannabinoids. The compound also contains a cumyl group, which is a structural motif that contributes to its high affinity for cannabinoid receptors.

The IUPAC name for 4CN-CUMYL-BUT7AICA is 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide. It has a molecular formula of C23H26N4O and a molecular weight of approximately 374.48 g/mol.

Pharmacology

4CN-CUMYL-BUT7AICA acts as a potent agonist at the CB1 and CB2 cannabinoid receptors. These receptors are part of the endocannabinoid system, which plays a crucial role in regulating various physiological processes, including pain sensation, mood, appetite, and memory.

The compound's high affinity for these receptors makes it a valuable tool in research settings, particularly in studies aimed at understanding the pharmacological effects of cannabinoid receptor activation.

Legal Status

The legal status of 4CN-CUMYL-BUT7AICA varies by country. In some jurisdictions, it may be classified as a controlled substance due to its potential for abuse and lack of medical use. Researchers should be aware of the legal regulations governing the use of synthetic cannabinoids in their respective countries.

Safety and Toxicology

As with many synthetic cannabinoids, the safety profile of 4CN-CUMYL-BUT7AICA is not well-established. It is important for researchers to exercise caution when handling this compound and to adhere to appropriate safety protocols. Potential risks include psychoactive effects, cardiovascular issues, and other adverse reactions.

Research Applications

4CN-CUMYL-BUT7AICA is primarily used in scientific research to study the effects of cannabinoid receptor activation. It can help elucidate the role of the endocannabinoid system in various physiological and pathological processes. Additionally, it may serve as a lead compound in the development of new therapeutic agents targeting cannabinoid receptors.

Also see

• Synthetic cannabinoids
• Cannabinoid receptor
• Endocannabinoid system
• CB1 receptor
• CB2 receptor